Ecoglip-TM Tablet PR

By Ecoglip-TM

Rx

10 Tablet PR in a Strip

Composition icon

Composition

Metformin(500mg) + Teneligliptin(20mg)

Manufacturer - Ozone Pharmaceuticals Ltd icon

Manufacturer - Ozone Pharmaceuticals Ltd

Ozone House, Block A-3, 1 LSC, Janak Puri, New Delhi – 110058

Expires on or after icon

Expires on or after

September, 2026

About Ecoglip-TM Tablet PR

Ecoglip-TM Tablet PR is a medication designed to help individuals with type 2 diabetes mellitus manage high blood sugar levels. By combining Teneligliptin and Metformin hydrochloride, it works to control blood glucose levels effectively. Teneligliptin acts by increasing insulin levels and reducing glucagon levels in the body, while Metformin hydrochloride decreases liver glucose production and intestinal glucose uptake. This dual action is beneficial in preventing serious complications of diabetes, such as kidney damage and blindness, as well as reducing the risk of heart attacks or strokes.

Patients can take Ecoglip-TM Tablet PR alone or in combination with other diabetes medications for optimal results. It is crucial to follow a healthy diet and engage in regular exercise alongside the medication to maximize its effectiveness. The dosage prescribed will depend on individual conditions, blood sugar levels, and concurrent medications. Taking the tablet with meals can help reduce the likelihood of experiencing stomach upset.

Consistent and timely consumption of Ecoglip-TM Tablet PR is essential to obtain the best results. It is recommended to follow the advice of healthcare providers and not discontinue usage without medical guidance. This medication plays a pivotal role in controlling blood sugar levels and preventing potential complications. Patients are advised to adhere to the recommended diet and exercise regimen as part of their diabetes management plan.

While generally well-tolerated, some common side effects of Ecoglip-TM Tablet PR may include diarrhea, nausea, vomiting, upset stomach, and headaches. Patients should be mindful of the possibility of low blood sugar levels (hypoglycemia) when taking other diabetes medications concurrently, such as insulin or sulfonylurea. It is important to be aware of the signs and symptoms of hypoglycemia to address them promptly.

Before initiating treatment with Ecoglip-TM Tablet PR, individuals should inform their healthcare provider of any existing kidney, liver, or heart conditions, pancreas issues, or significant alcohol consumption. Pregnant or breastfeeding women should consult their doctor before using this medication. Additionally, it is essential to disclose all other medications being taken to ensure safety and efficacy. Regular monitoring of kidney function and blood sugar levels is typically recommended during treatment to assess the drug's impact.


Benefits

Ecoglip-TM Tablet PR offers several benefits for individuals with Type 2 diabetes mellitus. This medication combines two powerful medicines that work together to effectively lower blood glucose levels. Managing blood glucose levels is crucial in diabetes care as it can help reduce the risk of serious complications associated with the condition, such as kidney damage, eye damage, nerve problems, and even the loss of limbs. By maintaining proper control over blood glucose levels with the help of Ecoglip-TM Tablet PR, individuals can also lower their risk of developing heart disease and stroke.


Consistent use of this medication, in conjunction with a healthy diet and regular exercise, can significantly improve the quality of life for individuals with Type 2 diabetes mellitus. By following the prescribed regimen, patients can lead a normal and healthy life while effectively protecting their future health. It is essential to adhere to the treatment plan outlined by healthcare providers to ensure maximum benefits and long-term health outcomes. Ecoglip-TM Tablet PR is a valuable tool in the management of diabetes, offering individuals a chance to take control of their health and well-being.


How to use the Ecoglip-TM Tablet PR

To properly use Ecoglip-TM Tablet PR, it is important to follow the advice of your doctor or carefully read the instructions on the label before using it. This medication should be taken with food. Make sure to adhere to the prescribed dosage and do not exceed it without consulting your healthcare provider. Taking Ecoglip-TM Tablet PR as directed can help you experience the full benefits of the medication while minimizing the risk of side effects. If you have any questions or concerns about how to use this medication, do not hesitate to reach out to your doctor for further guidance.


Uses of Ecoglip-TM Tablet PR

Ecoglip-TM Tablet PR is primarily used for the treatment of Type 2 diabetes mellitus. This medication helps in controlling blood sugar levels in individuals with this condition. By effectively managing glucose levels, Ecoglip-TM Tablet PR can assist in reducing the risk of complications associated with diabetes. It is important to follow the prescribed dosage and advice of a healthcare professional when using Ecoglip-TM Tablet PR to achieve optimal results in managing Type 2 diabetes mellitus.


What conditions Ecoglip-TM Tablet PR treats?

Ecoglip-TM Tablet PR is used to treat type 2 diabetes mellitus by controlling high blood sugar levels. This helps prevent complications of diabetes like kidney damage and blindness. Taking the medicine with a healthy diet and exercise routine is important. Common side effects may include upset stomach and headache. Individuals with certain medical conditions should consult their doctor before taking this medicine. Pregnant or breastfeeding women should also seek medical advice. It's crucial to follow your doctor's recommendations, as this medicine aims to control blood sugar levels and reduce the risk of serious complications associated with diabetes.


Should you consult a doctor?

If you experience any persistent side effects such as nausea, vomiting, headache, diarrhea, or low blood sugar level (hypoglycemia), you should seek medical attention promptly. Additionally, if you have a history of kidney, liver, or heart disease, pancreas issues, or if you consume alcohol excessively, consult your doctor before taking Ecoglip-TM Tablet PR. Pregnant or breastfeeding women should also seek medical advice before initiating this medication. It is crucial to inform your doctor about all medications you are currently taking to prevent any potential interactions. Regular monitoring of kidney function and blood sugar levels is essential during treatment. If you have concerns about the medication or if side effects persist, do not hesitate to consult your healthcare provider. Remember, your doctor is there to help you manage your condition effectively and safely.


Side effects of Ecoglip-TM Tablet PR

When taking Ecoglip-TM Tablet PR, some possible side effects may occur. These side effects are usually mild and temporary, often improving as your body gets used to the medication. Common side effects include nausea, vomiting, headache, hypoglycemia (low blood glucose level), and diarrhea. If these side effects persist or cause concern, it is important to consult your doctor for further evaluation and guidance.


Safety advice

scroll

liver

Ecoglip-TM Tablet PR should be avoided by patients with liver disease as it may not be safe for them. It is important to consult your doctor before using this medication to ensure your liver health is not at risk.

scroll

kidney

Ecoglip-TM Tablet PR requires caution in patients with kidney disease. Dose adjustment and monitoring may be necessary. It is not recommended for severe kidney disease. Regular kidney function tests are advisable during the treatment.

scroll

alcohol

It is unsafe to drink alcohol while taking Ecoglip-TM Tablet PR.

scroll

driving

When taking Ecoglip-TM Tablet PR, avoid driving if you have symptoms affecting concentration and reaction time. It is unsure if this medication impacts driving ability.

scroll

pregnancy

Ecoglip-TM Tablet PR may be harmful during pregnancy, based on animal studies. Consult your doctor, who will consider the risks and benefits before prescribing it.

scroll

breastfeeding

Ecoglip-TM Tablet PR is considered unsafe for breastfeeding. Limited data shows potential harm to the baby as the drug may pass into breastmilk.


Consumption warning before consuming Ecoglip-TM Tablet PR

Before consuming Ecoglip-TM Tablet PR, it is essential to note that this medication helps control high blood sugar levels in individuals with type 2 diabetes. It aids in preventing severe diabetes-related complications and may lower the risk of heart attack or stroke. Ecoglip-TM Tablet PR is usually prescribed alone or in combination with other diabetes medications for optimal efficacy when paired with a balanced diet and regular exercise routine.


Take this medication consistently at the same time daily unless advised otherwise by your healthcare provider. Its effectiveness is crucial for maintaining stable blood sugar levels and reducing future complications. Adhering to the prescribed diet and exercise regimen is fundamental in managing diabetes effectively.


Common side effects may include stomach discomfort, headache, diarrhea, nausea, and vomiting. Hypoglycemia (low blood sugar levels) may occur, especially when combined with insulin or sulfonylurea medications. It's imperative to recognize and manage hypoglycemia promptly.


Inform your doctor about any history of kidney, liver, or heart disease, pancreatic issues, or alcohol consumption. Pregnant or breastfeeding individuals should consult their healthcare provider before starting the medication. Be cautious of potential interactions with other medications, and avoid excessive alcohol consumption as it can impact blood glucose levels. Regular monitoring of kidney function and blood sugar levels is necessary during treatment.


What if you forgot to take Ecoglip-TM Tablet PR?

If you forget to take a Ecoglip-TM Tablet PR dose, try to take it as soon as you remember. However, if it is close to the time for your next scheduled dose, it is better to skip the missed one and stick to your usual dosing routine. Avoid taking a double dose to make up for the missed one, as this can increase the risk of side effects.


Related lab tests

When taking Ecoglip-TM Tablet PR, it is important to monitor your glucose levels regularly through specific lab tests. These tests help to keep track of how well the medication is working for you. The first test is the Glucose - Fasting Blood test, which measures the amount of sugar in your blood after fasting for a certain period of time. The second test is the Glucose - Postprandial Blood test, which checks your blood sugar levels after eating. Lastly, the Glycosylated Hemoglobin test, also known as HbA1c, shows your average blood sugar level over the past 2-3 months. These tests are essential in managing diabetes and ensuring the effectiveness of Ecoglip-TM Tablet PR.


Related Lab Tests:

1. Glucose - Fasting Blood

2. Glucose - Postprandial Blood

3. Glycosylated Hemoglobin (HbA1c)


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

50

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 01-Oct-2024